C M Bidwell & Associates LTD Cerus Corp Transaction History
C M Bidwell & Associates LTD
- $162 Million
- Q3 2024
A detailed history of C M Bidwell & Associates LTD transactions in Cerus Corp stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 192 shares of CERS stock, worth $343. This represents 0.0% of its overall portfolio holdings.
Number of Shares
192
Previous 192
-0.0%
Holding current value
$343
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CERS
# of Institutions
156Shares Held
148MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$34.9 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$32.6 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$24.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$19.4 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$15.3 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $317M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...